Skip to Content

Tasigna, what is the death rate of individuals using this new cancer medication?

Responses (1)

robo 11 Aug 2009

from Tasigna Professional Information at

Sudden Deaths
"... There were five sudden deaths reported in patients receiving nilotinib in an on-going study (n=867; 0.6%). A similar incidence was also reported in the expanded access program. The relative early occurrence of some of these deaths relative to the initiation of nilotinib suggests the possibility that ventricular repolarization abnormalities may have contributed to their occurrence... " free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Similar Questions